< Turner White Communications - Self-Assessment Questions: Answer
Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Interactive:
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Quiz
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Exams
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map
Self-Assessment Questions

Family Medicine


Answer 5
  1. Rofecoxib. Rofecoxib is used to treat osteoarthritis, not osteoporosis. Estrogen is the initial drug of choice for both prevention and treatment of osteoporosis. It can be given by an oral or transdermal route and in combination with progesterone when needed. Alendronate and risedronate are approved bisphosphonates for prevention and treatment of osteoporosis. Raloxifene is the only approved selective estrogen receptor modulator for prevention and treatment of osteoporosis. Raloxifene is an option for patients who cannot or will not take estrogen. Calcitonin is approved for both prevention and treatment of osteoporosis.

Click here to return to the questions

 

Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 1/04/08 • kkj